Advancements in Medical Technologies Drive Growth for Noninvasive Cancer Treatment Solution

0
149


Radiosurgery Systems Market Size

Radiosurgery Systems Market Size

PORTLAND, OREGON, UNITED STATES, March 9, 2023 /EINPresswire.com/ — ๐‘๐š๐๐ข๐จ๐ฌ๐ฎ๐ซ๐ ๐ž๐ซ๐ฒ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐š๐ญ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ –

According to the report, the global radiosurgery systems industry was estimated at $2.10 billion in 2021, and is anticipated to hit $3.98 billion by 2031, registering a CAGR of 6.7% from 2022 to 2031.

Radiosurgery systems are medical devices that use focused beams of radiation to precisely target and treat specific areas of the body, often used to treat tumors or other abnormal growths.

The radiation beams are delivered from various angles around the body, converging on the targeted area to deliver a high dose of radiation to the tumor while minimizing radiation exposure to surrounding healthy tissue.

The goal of radiosurgery is to destroy the tumor cells while minimizing damage to surrounding healthy tissue, and it is often used as an alternative to traditional surgery or radiation therapy.

Radiosurgery systems are typically used in conjunction with advanced imaging techniques to help guide the radiation beams to the targeted area with great accuracy, ensuring that the treatment is delivered to the right place with minimal side effects.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐š๐ญ: https://www.alliedmarketresearch.com/request-sample/15210

๐‚๐จ๐ฏ๐ข๐-๐Ÿ๐Ÿ— ๐ฌ๐œ๐ž๐ง๐š๐ซ๐ข๐จ-

The majority of radiotherapy cases were either postponed or rescheduled due to conversion of surgical centers into Covid hospitals.

Thus, it caused scarcity of PPE kits for other surgical processes which impeded the market growth. At the same time, decrease in the number of diagnostic and investigation tests for cancer had a negative impact on the market.

๐“๐ก๐ž ๐‚๐Ž๐•๐ˆ๐ƒ-๐Ÿ๐Ÿ— ๐ฉ๐š๐ง๐๐ž๐ฆ๐ข๐œ ๐ก๐š๐ฌ ๐ก๐š๐ ๐›๐จ๐ญ๐ก ๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐ž ๐š๐ง๐ ๐ง๐ž๐ ๐š๐ญ๐ข๐ฏ๐ž ๐ข๐ฆ๐ฉ๐š๐œ๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ž ๐‘๐š๐๐ข๐จ๐ฌ๐ฎ๐ซ๐ ๐ž๐ซ๐ฒ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ.

The COVID-19 pandemic has had both positive and negative impacts on the use of Radiosurgery Systems in the medical industry.

On the positive side, the pandemic has increased the adoption of telemedicine and remote treatment options, which has made it possible for more patients to receive Radiosurgery treatment without having to physically visit a medical facility. This has allowed patients to receive treatment while minimizing the risk of exposure to COVID-19.

On the negative side, the pandemic has also led to delays and cancellations of non-urgent medical procedures, including Radiosurgery treatments, due to the strain on healthcare resources and the need to prioritize COVID-19 patients. This has resulted in some patients experiencing delays in receiving their treatment, which could potentially affect their outcomes.

Overall, the pandemic has highlighted the importance of advanced medical technologies like Radiosurgery Systems, which can help deliver effective treatments while minimizing the risks associated with traditional surgical procedures.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ- https://www.alliedmarketresearch.com/purchase-enquiry/15210

๐‘๐š๐๐ข๐จ๐ฌ๐ฎ๐ซ๐ ๐ž๐ซ๐ฒ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ ๐š๐ซ๐ž ๐ฉ๐ซ๐ข๐ฆ๐š๐ซ๐ข๐ฅ๐ฒ ๐ฎ๐ฌ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐ฆ๐ž๐๐ข๐œ๐š๐ฅ ๐Ÿ๐ข๐ž๐ฅ๐ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐ญ๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐จ๐Ÿ ๐ญ๐ฎ๐ฆ๐จ๐ซ๐ฌ ๐š๐ง๐ ๐จ๐ญ๐ก๐ž๐ซ ๐š๐›๐ง๐จ๐ซ๐ฆ๐š๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก๐ฌ ๐ข๐ง ๐ฏ๐š๐ซ๐ข๐จ๐ฎ๐ฌ ๐ฉ๐š๐ซ๐ญ๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐›๐จ๐๐ฒ. ๐“๐ก๐ž๐ฌ๐ž ๐ฌ๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ ๐š๐ซ๐ž ๐จ๐Ÿ๐ญ๐ž๐ง ๐ฎ๐ฌ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฆ๐ž๐๐ข๐œ๐š๐ฅ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ:

Radiation Oncology: Radiosurgery systems are widely used in radiation oncology for the treatment of cancer, including brain, lung, prostate, and liver cancer.

Neurosurgery: Radiosurgery systems are used in neurosurgery to treat conditions such as arteriovenous malformations, brain tumors, and trigeminal neuralgia.

Spine Surgery: Radiosurgery systems can be used in spine surgery to treat spinal tumors, vertebral metastases, and other conditions.

Cardiology: Radiosurgery systems can also be used in cardiology to treat arrhythmias, including atrial fibrillation.

Dermatology: Radiosurgery systems are also used in dermatology to remove skin lesions and treat skin cancer.

Veterinary Medicine: Radiosurgery systems are also used in veterinary medicine for the treatment of tumors and other conditions in animals.

Overall, Radiosurgery Systems have a broad range of applications in various medical segments and can provide effective and minimally invasive treatments for a variety of conditions.

๐Š๐ž๐ฒ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ-

Elekta AB (Innovator)
Avocure
Brain LAB
Integra Life Sciences Holding Corp
Ion Beam Applications SA
Accuray Incorporated
ZAP surgical System Inc.
Medtronic
Mevion Medical Systems, Inc.
Nordion Inc.
Reflexion Medical
Siemens (Varian Medical Systems)
Atrium Health
Summit Cancer Centers
ViewRay
Xcision Medical Systems
Vision RT

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง: https://www.alliedmarketresearch.com/request-for-customization/15210

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

North America held the major share in 2021, generating more than two-thirds of the global radiosurgery systems market. Increase in the number of research activities, technological advancements in the healthcare sector, rise in the prevalence of chronic diseases, and presence of key players drive the market growth. The Asia-Pacific region, on the other hand, would garner the fastest CAGR of 7.5% by 2031. Surge in expenditure by government organizations to develop the healthcare sector, surge in prevalence of chronic diseases, and rise in the geriatric population fuel the market growth.

North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest Of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest Of Asia-Pacific)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest Of LAMEA)

๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:

Skin Biopsy Market

Dystonia Drugs Market

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+1-800-792-5285
email us here





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here